P
SEM

&Partners’s Select Medical SEM Stock Holding History

&Partners’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,806
Closed -$216K – 2345
2025
Q3 		$216K Sell
16,806
-2,702
-14% -$36K ﹤0.01% 1930
2025
Q2 		$296K Buy
19,508
+3,234
+20% +$50.5K ﹤0.01% 1629
2025
Q1 		$273K Buy
16,274
+197
+1% +$3.63K ﹤0.01% 1453
2024
Q4 		$296K Buy
16,077
+3,762
+31% +$72.5K ﹤0.01% 1346
2024
Q3 		$231K Buy
+12,315
New +$236K ﹤0.01% 1239

Other funds holding SEM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $295M AUM 40.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

&Partners's SEM Position: Q4 2025 in Review

&Partners sold out of Select Medical (SEM) in Q4 2025, closing a stake of 16,806 shares — an estimated $216K sold.

&Partners first reported a position in SEM in Q3 2024 and held it in 5 quarters. The position peaked at $296K in Q2 2025. 268 funds tracked by Wall St. Rank hold SEM as of Q4 2025.

  • &Partners reported no remaining Select Medical position as of Q4 2025 after selling out during the quarter.
  • &Partners sold 16,806 Select Medical shares in Q4 2025, an estimated $216K.
  • &Partners first reported a position in Select Medical in Q3 2024 and held it in 5 quarters.
  • &Partners's Select Medical position peaked at $296K in Q2 2025.
  • 268 funds tracked by Wall St. Rank held Select Medical as of Q4 2025.

Based on &Partners's 13F filing for Q4 2025, filed 17 Feb 2026.